
Disposable vapes more toxic and carcinogenic than cigarettes, study shows
Illegal disposable e-cigarettes, also known as vapes, may present a greater danger than traditional cigarettes, according to a study from the University of California (UC) Davis.
The research, published in the journal ACS Central Science, found that hazardous levels of several toxic heavy metals in illegal vapes could present a high cancer risk.
Researchers used a special instrument to test the puffs from three popular vape brands — ELF Bar, Flum Pebble and Esco — that are not FDA-authorized for use in the U.S., but are widely sold by retailers.
Three heavy metals — lead, nickel and antimony — were detected in all heavily flavored and lightly flavored devices that were tested.
These metals are classified as carcinogens, potentially leading to various types of cancers, such as skin, lung and kidney, according to the National Institutes of Health (NIH).
All vapors exceeded the cancer risk limits for nickel, which has been linked to cardiovascular disease, asthma, lung fibrosis and respiratory tract cancer, per NIH.
Brett Poulin, senior study author and assistant professor at the UC Davis Department of Environmental Toxicology, told Fox News Digital that he was shocked at the levels of toxic metals.
"When I analyzed the first samples, the lead concentrations were so high that I genuinely thought the instrument was broken," he said. "The levels far exceeded anything in our past data, or even the published literature."
One of the brands tested exposes users to as much lead as smoking 19 packs of cigarettes, the researchers discovered.
Additionally, most of the disposable e-cigarettes tested in the study were found to contain greater levels of metals and metalloids than older refillable vapes.
At one point, Poulin said, he physically opened a device and discovered that it was using leaded copper alloys, which are metals made primarily of copper with small amounts of lead.
"These materials leached dangerous levels of lead into the e-liquid, even without the device being used," Poulin told Fox News Digital.
"It remains unclear whether this was an intentional design choice, a cost-cutting measure or a manufacturing oversight."
"This neurotoxin poses serious health risks, particularly to children and adolescents."
There is no known safe level of lead exposure, according to Poulin.
"This neurotoxin poses serious health risks, particularly to children and adolescents, who are especially vulnerable."
Daniel Sterman, M.D., director of the Pulmonary Oncology Program at the NYU Langone Perlmutter Cancer Center, told Fox News Digital that the study "clearly" demonstrates high concentrations of metal.
"There are several health risks of vaping that we enumerate for our patients and their family members, [such as] risks of various lung diseases, including asthma, COPD and lung cancer," said Sterman, who was not involved in the study.
The doctor noted that while it is challenging to establish a direct link of causation between disposable vapes and cancer, he does see cancer patients who use the devices.
"Disposable vapes should be highly regulated by local, state and federal agencies, and restricted to those individuals 21 years or older," Sterman recommends.
The doctor also called for the packaging on disposable vapes to clearly outline the many health risks, "particularly to teenagers and young adults."
One of the primary limitations of the study was that only three disposable e-cigarette brands were tested out of the hundreds currently on the market.
There are distinct differences in the metal leaching and profiles across all three brands, Poulin shared.
"We still know very little about the metal content in the vast majority of untested disposable e-cigarette products," he said. "This gap in knowledge poses a significant public health concern, especially given the popularity of these devices."
A spokesperson for the China-based brand, ELFBAR, told Fox News Digital that they refute the results of the study, claiming that they stopped shipments in May 2023.
Due to ongoing trademark litigation, they are unable to market or sell products in the U.S., the company stated.
"This market void has led to a surge in counterfeits, imitations and illicit variations misusing our brand name," the spokesperson said. "As such, we have every reason to believe the devices tested in this study are not genuine and were not manufactured by ELFBAR."
The spokesperson acknowledged that smoking remains the leading cause of preventable death and disease worldwide, noting that the recent study "continues to undermine public understanding of smoking cessation."
The other two brands tested in the study did not respond to requests for comment.
"Disposable vapes should be highly regulated by local, state and federal agencies and restricted to those individuals 21 years or older."
Electronic cigarette use among adults increased from 4.5% in 2019 to 6.5% in 2023, according to the U.S. Centers for Disease Control and Prevention (CDC).
Men are more likely to vape than women, while 15.5% of young adults between the ages of 21 and 24 reported using e-cigarettes, the above source states.
For more Health articles, visit www.foxnews.com/health
The UC Davis study received support from the University of California Tobacco-Related Disease Research Program Grant and the California Agricultural Experiment Station.

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles

Associated Press
6 minutes ago
- Associated Press
Kaplan Fox Encourages Investors of Hims & Hers Health, Inc. (HIMS) to Contact the Firm Before Lead Plaintiff Deadline on August 25, 2025
NEW YORK, NY - June 28, 2025 ( NEWMEDIAWIRE ) - Kaplan Fox & Kilsheimer LLP announces that class action lawsuits have been filed against Hims & Hers Health, Inc. ('Hims & Hers' or the 'Company') (NYSE: HIMS) on behalf of investors that purchased or otherwise acquired Hims & Hers securities between April 29, 2025 and June 23, 2025 (the 'Class Period'). CLICK HERE TO JOIN THE CASE If you are an investor in Hims & Hers and have suffered losses, you may CLICK HERE to contact us. You may also contact Kaplan Fox by emailing [email protected] or by calling (646) 315-9003. DEADLINE REMINDER: If you are a member of the proposed Class, you may move the court no later than August 25, 2025 to serve as a lead plaintiff for the purported class. If you have losses we encourage you to contact us to learn more about the lead plaintiff process. You need not seek to become a lead plaintiff in order to share in any possible recovery. Hims & Hers operates a telehealth platform that connects customers to licensed healthcare professionals and offers a range of both prescription and non-prescription health and wellness products. On May 20, 2024, the Company announced the addition of GLP-1 injections to its comprehensive weight loss portfolio. Hims & Hers stated that '[p]roviding access to compounded GLP-1s means eligible customers can use medications with the same active ingredient as Ozempic(R) and Wegovy(R) without navigating the shortages and costs that are currently limiting access to the branded medications.' On April 29, 2025, Hims & Hers announced the first-step in a long-term collaboration with Novo Nordisk by providing 'a bundled offering of Novo Nordisk's FDA-approved Wegovy(R) on the Hims & Hers platform.' Then, on June 23, 2025, before the market opened, Novo Nordisk issued a press release announcing that it was terminating the collaboration with Hims & Hers, including that 'direct access to Wegovy(R) will no longer be available' to Hims & Hers, 'based on Hims & Hers deceptive promotion and selling of illegitimate, knockoff versions of Wegovy(R) that put patient safety at risk.' The press release stated that Hims & Hers 'has failed to adhere to the law which prohibits mass sales of compounded drugs under the false guise of 'personalization.'' The press release further stated '[b]ased on Novo Nordisk's investigation, the 'semaglutide' active pharmaceutical ingredients that are in the knock-off drugs sold by telehealth entities and compounding pharmacies are manufactured by foreign suppliers in China' that the 'FDA has never authorized or approved' according to a report from the Brookings Institute. Following this news, the price of Hims & Hers stock fell $22.24 per share, over 34%, to close at $41.98 per share on June 23, 2025. WHY CONTACT KAPLAN FOX - Kaplan Fox is a leading national law firm focusing on complex litigation with offices in New York, Oakland, Los Angeles, Chicago and New Jersey. With over 50 years of experience in securities litigation, Kaplan Fox offers the professional experience and track record that clients demand. Through prosecuting cases on the federal and state levels, Kaplan Fox has successfully shaped the law through winning many important decisions on behalf of our clients. For more information about Kaplan Fox & Kilsheimer LLP, you may visit our website at This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules. If you have any questions about this Notice, your rights, or your interests, please contact: CONTACT: Pamela A. Mayer KAPLAN FOX & KILSHEIMER LLP 800 Third Avenue, 38th Floor New York, New York 10022 (646) 315-9003 [email protected] Laurence D. King KAPLAN FOX & KILSHEIMER LLP 1999 Harrison Street, Suite 1560 Oakland, California 94612 (415) 772-4704 [email protected] Contacting or submitting information to Kaplan Fox & Kilsheimer LLP does not create an attorney-client relationship, nor an obligation on the part of Kaplan Fox to retain you as a client. View the original release on


Bloomberg
27 minutes ago
- Bloomberg
Federal Advisory Panels' Powers Just Got a Boost
So, it turns out to be a matter of some constitutional importance that the secretary of Health and Human Services has the power to fire the members of those pesky advisory committees whose recommendations on medical treatments can become binding on health insurers. Or so the Supreme Court said on Friday. No, the case in question wasn't about the vaccine advisory group that Secretary Robert F. Kennedy Jr. recently gutted. (We'll get back to that one.) The decision in Kennedy v. Braidwood Management, Inc., involved a different group, the US Preventive Services Task Force. Under the Affordable Care Act, most health insurers are required to cover that group's top recommended preventive services. The plaintiffs in Braidwood, who are covered because they self-insure, argued that the grant of binding authority to the task force was unconstitutional. 1
Yahoo
an hour ago
- Yahoo
19 beaches are closed in Massachusetts this weekend due to bacteria. Here's where
After the heat wave in Massachusetts this week, you may be in the mood to spend a day at the beach this weekend. However, if you're planning a weekend beach trip, you'll want to avoid the beaches closed due to unsafe swimming water. The Massachusetts Department of Public Health (MDPH) states that swimming in the water at these closed beaches poses a threat of illness due to high levels of bacteria. Symptoms of water-borne illness can range from nausea and vomiting to a sore throat and fever, or even rashes and infections. Heading into this weekend, 19 Massachusetts beaches are closed. Here's the full list. The following MA beaches, listed by town, are closed as of Friday, June 27: Andover: Pomps Pond (Bacterial Exceedance) Ashby: Damon Pond Beach (Bacterial Exceedance) Ashland: Ashland Reservoir Main Beach (Bacterial Exceedance) Ayer: Ayer Town Beach (Bacterial Exceedance) Bourne: Patuisset (Bacterial Exceedance) Brewster: Upper Mill Pond (Harmful Cyanobacteria Bloom) Danvers: Sandy Beach (Bacterial Exceedance) Framingham: Waushakum Beach (Bacterial Exceedance) Manchester: Magnolia (Bacterial Exceedance) Tuck's Point (Bacterial Exceedance) Marlborough: Henry F Collins Beach (Bacterial Exceedance) Natick: Cochituate State Park Beach (Harmful Cyanobacteria Bloom) Salem: Children's Island - Dock (Bacterial Exceedance) Saugus: Peckham Pond at Camp Nihan (Bacterial Exceedance) Templeton: Beamans Pond - Day Use (Bacterial Exceedance) Beamans Pond - Campground (Bacterial Exceedance) West Tisbury: Seth's Pond (Bacterial Exceedance) Winchester: Shannon Beach at Upper Mystic (Bacterial Exceedance) Most beaches are closed due to bacterial exceedance, meaning the levels of bacteria in the water are higher than the limits set by the MDPH. Those in the "other" category can be closed due to a variety of chemical or physical hazards, such as riptides and poor visibility. Beach parking: Want to park for free at the beach this summer in MA? Boston Beer Company can help Another popular beach is closed for the summer, but not due to bacteria. According to an announcement from the Department of Conservation and Recreation (DCR) on May 30, the main beach at Walden Pond in Concord will be closed for the season as the site undergoes construction. Red Cross Beach, another beach at Walden Pond, will still be open for the summer, but with no lifeguards present and limited parking availability. Over the summer, Walden Pond will be getting a new $6.1 million bathhouse, according to the DCR. The new single-story, 2,700 square-foot building will replace the current two-story bathhouse from 1947, which is not ADA compliant. This project will bring Walden Pond State Reservation's facility up to federal and state accessibility requirements. More: Popular MA beach to stay closed all summer due to construction. Here's where According to the MDPH website, beaches can only re-open when their bacteria levels are back within the safe range, so there is no set amount of time for a closure. The status of a closed beach can be checked on the website's water quality dashboard, which is updated at 9:30 a.m. and 12:30 p.m. daily. This article originally appeared on The Patriot Ledger: Which Massachusetts beaches are closed this weekend? Here's a list